HEADER MEMBRANE PROTEIN 06-MAR-20 6Y92 TITLE STRUCTURE OF FULL-LENGTH CD20 IN COMPLEX WITH OFATUMUMAB FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: B-LYMPHOCYTE ANTIGEN CD20; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: B-LYMPHOCYTE SURFACE ANTIGEN B1,BP35,LEUKOCYTE SURFACE COMPND 5 ANTIGEN LEU-16,MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: FULL-LENGTH WILD TYPE HUMAN CD20; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: OFATUMUMAB FAB LIGHT CHAIN; COMPND 10 CHAIN: D, L; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: OFATUMUMAB FAB HEAVY CHAIN; COMPND 14 CHAIN: C, H; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL: B-LYMPHOCYTE; SOURCE 6 GENE: MS4A1, CD20; SOURCE 7 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 8 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: HEK-293F; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PCDNA3.1+; SOURCE 13 MOL_ID: 2; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 18 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 20 EXPRESSION_SYSTEM_CELL_LINE: HEK-293F; SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: IGG1 EXPRESSION VECTOR; SOURCE 23 MOL_ID: 3; SOURCE 24 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 25 ORGANISM_COMMON: HUMAN; SOURCE 26 ORGANISM_TAXID: 9606; SOURCE 27 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 28 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 29 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 30 EXPRESSION_SYSTEM_CELL_LINE: HEK-293F; SOURCE 31 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 32 EXPRESSION_SYSTEM_PLASMID: IGG1 EXPRESSION VECTOR KEYWDS CANCER IMMUNOTHERAPY, THERAPEUTIC ANTIBODY, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR A.KUMAR,N.REYES REVDAT 1 26-AUG-20 6Y92 0 JRNL AUTH A.KUMAR,C.PLANCHAIS,R.FRONZES,H.MOUQUET,N.REYES JRNL TITL BINDING MECHANISMS OF THERAPEUTIC ANTIBODIES TO HUMAN CD20. JRNL REF SCIENCE V. 369 793 2020 JRNL REFN ESSN 1095-9203 JRNL PMID 32792392 JRNL DOI 10.1126/SCIENCE.ABB8008 REMARK 2 REMARK 2 RESOLUTION. 4.73 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : EPU, GCTF, UCSF CHIMERA, COOT, REMARK 3 CRYOSPARC, CRYOSPARC, CRYOSPARC, REMARK 3 CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 3GIZ REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : RIGID BODY FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.730 REMARK 3 NUMBER OF PARTICLES : 99146 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 6Y92 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1292107051. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : FULL-LENGTH HUMAN ANTIGEN CD20 REMARK 245 IN COMPLEX WITH OFATUMUMAB FAB; REMARK 245 FULL-LENGTH HUMAN CD20; REMARK 245 OFATUMUMAB FAB REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.20 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 2540 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS GLACIOS REMARK 245 DETECTOR TYPE : FEI FALCON III (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 40.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 200 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 71160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -86.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D, C, H, L, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CE1 PHE B 203 CAC Y01 B 303 1.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS B 183 CA - CB - SG ANGL. DEV. = 7.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO D 15 69.58 -69.14 REMARK 500 ALA D 51 16.46 57.34 REMARK 500 ASP C 90 49.56 -85.54 REMARK 500 ASP C 153 60.71 61.11 REMARK 500 ASP H 90 49.53 -85.57 REMARK 500 ASP H 153 60.76 61.08 REMARK 500 PRO L 15 69.61 -69.25 REMARK 500 ALA L 51 16.47 57.28 REMARK 500 MET B 71 30.89 -96.10 REMARK 500 LYS B 148 -62.19 -96.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 Y01 A 302 REMARK 610 Y01 B 302 REMARK 610 Y01 B 303 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Y01 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Y01 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Y01 B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Y01 B 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide Y01 B 301 and LYS B REMARK 800 50 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide Y01 B 303 and PHE B REMARK 800 203 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-10731 RELATED DB: EMDB REMARK 900 FULL-LENGTH CD20 IN COMPLEX WITH RITUXIMAB FAB REMARK 900 RELATED ID: EMD-10732 RELATED DB: EMDB REMARK 900 STRUCTURE OF FULL-LENGTH CD20 IN COMPLEX WITH OFATUMUMAB FAB REMARK 900 RELATED ID: EMD-10733 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-10734 RELATED DB: EMDB DBREF 6Y92 A 41 218 UNP P11836 CD20_HUMAN 41 218 DBREF 6Y92 D 1 211 PDB 6Y92 6Y92 1 211 DBREF 6Y92 C 1 222 PDB 6Y92 6Y92 1 222 DBREF 6Y92 H 1 222 PDB 6Y92 6Y92 1 222 DBREF 6Y92 L 1 211 PDB 6Y92 6Y92 1 211 DBREF 6Y92 B 41 218 UNP P11836 CD20_HUMAN 41 218 SEQRES 1 A 178 THR GLN SER PHE PHE MET ARG GLU SER LYS THR LEU GLY SEQRES 2 A 178 ALA VAL GLN ILE MET ASN GLY LEU PHE HIS ILE ALA LEU SEQRES 3 A 178 GLY GLY LEU LEU MET ILE PRO ALA GLY ILE TYR ALA PRO SEQRES 4 A 178 ILE CYS VAL THR VAL TRP TYR PRO LEU TRP GLY GLY ILE SEQRES 5 A 178 MET TYR ILE ILE SER GLY SER LEU LEU ALA ALA THR GLU SEQRES 6 A 178 LYS ASN SER ARG LYS CYS LEU VAL LYS GLY LYS MET ILE SEQRES 7 A 178 MET ASN SER LEU SER LEU PHE ALA ALA ILE SER GLY MET SEQRES 8 A 178 ILE LEU SER ILE MET ASP ILE LEU ASN ILE LYS ILE SER SEQRES 9 A 178 HIS PHE LEU LYS MET GLU SER LEU ASN PHE ILE ARG ALA SEQRES 10 A 178 HIS THR PRO TYR ILE ASN ILE TYR ASN CYS GLU PRO ALA SEQRES 11 A 178 ASN PRO SER GLU LYS ASN SER PRO SER THR GLN TYR CYS SEQRES 12 A 178 TYR SER ILE GLN SER LEU PHE LEU GLY ILE LEU SER VAL SEQRES 13 A 178 MET LEU ILE PHE ALA PHE PHE GLN GLU LEU VAL ILE ALA SEQRES 14 A 178 GLY ILE VAL GLU ASN GLU TRP LYS ARG SEQRES 1 D 211 GLU ILE VAL LEU THR GLN SER PRO ALA THR LEU SER LEU SEQRES 2 D 211 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 D 211 GLN SER VAL SER SER TYR LEU ALA TRP TYR GLN GLN LYS SEQRES 4 D 211 PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR ASP ALA SER SEQRES 5 D 211 ASN ARG ALA THR GLY ILE PRO ALA ARG PHE SER GLY SER SEQRES 6 D 211 GLY SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU SEQRES 7 D 211 GLU PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN ARG SEQRES 8 D 211 SER ASN TRP PRO ILE THR PHE GLY GLN GLY THR ARG LEU SEQRES 9 D 211 GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 D 211 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 D 211 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 D 211 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 D 211 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 D 211 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 D 211 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 D 211 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 D 211 PHE ASN ARG SEQRES 1 C 216 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 C 216 PRO GLY ARG SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 C 216 PHE THR PHE ASN ASP TYR ALA MET HIS TRP VAL ARG GLN SEQRES 4 C 216 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER THR ILE SER SEQRES 5 C 216 TRP ASN SER GLY SER ILE GLY TYR ALA ASP SER VAL LYS SEQRES 6 C 216 GLY ARG PHE THR ILE SER ARG ASP ASN ALA LYS LYS SER SEQRES 7 C 216 LEU TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 C 216 ALA LEU TYR TYR CYS ALA LYS ASP ILE GLN TYR GLY ASN SEQRES 9 C 216 TYR TYR TYR GLY MET ASP VAL TRP GLY GLN GLY THR THR SEQRES 10 C 216 VAL THR VAL SER SER ALA SER THR LYS GLY PRO SER VAL SEQRES 11 C 216 PHE PRO LEU ALA PRO GLY GLY THR ALA ALA LEU GLY CYS SEQRES 12 C 216 LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SER SEQRES 13 C 216 TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS THR PHE SEQRES 14 C 216 PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SER SEQRES 15 C 216 SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR GLN SEQRES 16 C 216 THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN THR SEQRES 17 C 216 LYS VAL ASP LYS LYS VAL GLU PRO SEQRES 1 H 216 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 216 PRO GLY ARG SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 H 216 PHE THR PHE ASN ASP TYR ALA MET HIS TRP VAL ARG GLN SEQRES 4 H 216 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER THR ILE SER SEQRES 5 H 216 TRP ASN SER GLY SER ILE GLY TYR ALA ASP SER VAL LYS SEQRES 6 H 216 GLY ARG PHE THR ILE SER ARG ASP ASN ALA LYS LYS SER SEQRES 7 H 216 LEU TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 H 216 ALA LEU TYR TYR CYS ALA LYS ASP ILE GLN TYR GLY ASN SEQRES 9 H 216 TYR TYR TYR GLY MET ASP VAL TRP GLY GLN GLY THR THR SEQRES 10 H 216 VAL THR VAL SER SER ALA SER THR LYS GLY PRO SER VAL SEQRES 11 H 216 PHE PRO LEU ALA PRO GLY GLY THR ALA ALA LEU GLY CYS SEQRES 12 H 216 LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SER SEQRES 13 H 216 TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS THR PHE SEQRES 14 H 216 PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SER SEQRES 15 H 216 SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR GLN SEQRES 16 H 216 THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN THR SEQRES 17 H 216 LYS VAL ASP LYS LYS VAL GLU PRO SEQRES 1 L 211 GLU ILE VAL LEU THR GLN SER PRO ALA THR LEU SER LEU SEQRES 2 L 211 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 L 211 GLN SER VAL SER SER TYR LEU ALA TRP TYR GLN GLN LYS SEQRES 4 L 211 PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR ASP ALA SER SEQRES 5 L 211 ASN ARG ALA THR GLY ILE PRO ALA ARG PHE SER GLY SER SEQRES 6 L 211 GLY SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU SEQRES 7 L 211 GLU PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN ARG SEQRES 8 L 211 SER ASN TRP PRO ILE THR PHE GLY GLN GLY THR ARG LEU SEQRES 9 L 211 GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 L 211 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 L 211 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 L 211 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 L 211 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 L 211 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 L 211 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 L 211 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 L 211 PHE ASN ARG SEQRES 1 B 178 THR GLN SER PHE PHE MET ARG GLU SER LYS THR LEU GLY SEQRES 2 B 178 ALA VAL GLN ILE MET ASN GLY LEU PHE HIS ILE ALA LEU SEQRES 3 B 178 GLY GLY LEU LEU MET ILE PRO ALA GLY ILE TYR ALA PRO SEQRES 4 B 178 ILE CYS VAL THR VAL TRP TYR PRO LEU TRP GLY GLY ILE SEQRES 5 B 178 MET TYR ILE ILE SER GLY SER LEU LEU ALA ALA THR GLU SEQRES 6 B 178 LYS ASN SER ARG LYS CYS LEU VAL LYS GLY LYS MET ILE SEQRES 7 B 178 MET ASN SER LEU SER LEU PHE ALA ALA ILE SER GLY MET SEQRES 8 B 178 ILE LEU SER ILE MET ASP ILE LEU ASN ILE LYS ILE SER SEQRES 9 B 178 HIS PHE LEU LYS MET GLU SER LEU ASN PHE ILE ARG ALA SEQRES 10 B 178 HIS THR PRO TYR ILE ASN ILE TYR ASN CYS GLU PRO ALA SEQRES 11 B 178 ASN PRO SER GLU LYS ASN SER PRO SER THR GLN TYR CYS SEQRES 12 B 178 TYR SER ILE GLN SER LEU PHE LEU GLY ILE LEU SER VAL SEQRES 13 B 178 MET LEU ILE PHE ALA PHE PHE GLN GLU LEU VAL ILE ALA SEQRES 14 B 178 GLY ILE VAL GLU ASN GLU TRP LYS ARG HET Y01 A 301 35 HET Y01 A 302 31 HET Y01 B 301 28 HET Y01 B 302 30 HET Y01 B 303 28 HET Y01 B 304 35 HETNAM Y01 CHOLESTEROL HEMISUCCINATE FORMUL 7 Y01 6(C31 H50 O4) HELIX 1 AA1 SER A 49 LEU A 70 1 22 HELIX 2 AA2 PRO A 79 TRP A 85 1 7 HELIX 3 AA3 TRP A 85 LEU A 101 1 17 HELIX 4 AA4 GLY A 115 ASN A 140 1 26 HELIX 5 AA5 LEU A 152 ALA A 157 1 6 HELIX 6 AA6 SER A 177 TYR A 182 1 6 HELIX 7 AA7 CYS A 183 TRP A 216 1 34 HELIX 8 AA8 SER D 121 GLY D 128 1 8 HELIX 9 AA9 SER D 182 LYS D 188 1 7 HELIX 10 AB1 SER C 165 ALA C 167 5 3 HELIX 11 AB2 SER H 165 ALA H 167 5 3 HELIX 12 AB3 SER L 121 GLY L 128 1 8 HELIX 13 AB4 SER L 182 LYS L 188 1 7 HELIX 14 AB5 SER B 49 LEU B 70 1 22 HELIX 15 AB6 PRO B 79 VAL B 84 1 6 HELIX 16 AB7 TRP B 85 LEU B 101 1 17 HELIX 17 AB8 LYS B 114 ASN B 140 1 27 HELIX 18 AB9 LEU B 152 ALA B 157 1 6 HELIX 19 AC1 SER B 177 TRP B 216 1 40 SHEET 1 AA1 2 LEU D 4 GLN D 6 0 SHEET 2 AA1 2 CYS D 23 ALA D 25 -1 O ARG D 24 N THR D 5 SHEET 1 AA2 3 THR D 20 LEU D 21 0 SHEET 2 AA2 3 ASP D 70 THR D 74 -1 O LEU D 73 N LEU D 21 SHEET 3 AA2 3 SER D 63 SER D 67 -1 N SER D 65 O THR D 72 SHEET 1 AA3 4 ARG D 45 TYR D 49 0 SHEET 2 AA3 4 ALA D 34 GLN D 38 -1 N GLN D 37 O ARG D 45 SHEET 3 AA3 4 VAL D 85 GLN D 89 -1 O TYR D 87 N TYR D 36 SHEET 4 AA3 4 THR D 102 ARG D 103 -1 O THR D 102 N TYR D 86 SHEET 1 AA4 2 ALA D 130 PHE D 139 0 SHEET 2 AA4 2 TYR D 173 LEU D 181 -1 O LEU D 175 N LEU D 136 SHEET 1 AA5 4 ALA D 153 LEU D 154 0 SHEET 2 AA5 4 LYS D 145 VAL D 150 -1 N VAL D 150 O ALA D 153 SHEET 3 AA5 4 TYR D 192 THR D 197 -1 O GLU D 195 N GLN D 147 SHEET 4 AA5 4 VAL D 205 SER D 208 -1 O VAL D 205 N VAL D 196 SHEET 1 AA6 4 VAL C 5 SER C 7 0 SHEET 2 AA6 4 SER C 21 ALA C 23 -1 O SER C 21 N SER C 7 SHEET 3 AA6 4 SER C 78 MET C 83 -1 O LEU C 79 N CYS C 22 SHEET 4 AA6 4 PHE C 68 SER C 71 -1 N THR C 69 O GLN C 82 SHEET 1 AA7 5 GLY C 59 TYR C 60 0 SHEET 2 AA7 5 LEU C 45 THR C 50 -1 N THR C 50 O GLY C 59 SHEET 3 AA7 5 MET C 34 GLN C 39 -1 N ARG C 38 O GLU C 46 SHEET 4 AA7 5 ALA C 97 ASP C 99 -1 O ALA C 97 N HIS C 35 SHEET 5 AA7 5 MET C 109 TRP C 112 -1 O VAL C 111 N LYS C 98 SHEET 1 AA8 2 LEU C 93 TYR C 94 0 SHEET 2 AA8 2 THR C 116 THR C 117 -1 O THR C 116 N TYR C 94 SHEET 1 AA9 3 SER C 129 LEU C 133 0 SHEET 2 AA9 3 THR C 144 LYS C 152 -1 O LYS C 152 N SER C 129 SHEET 3 AA9 3 SER C 186 PRO C 194 -1 O VAL C 191 N LEU C 147 SHEET 1 AB1 3 THR C 160 TRP C 163 0 SHEET 2 AB1 3 ILE C 204 ASN C 208 -1 O ASN C 206 N SER C 162 SHEET 3 AB1 3 VAL C 216 LYS C 219 -1 O VAL C 216 N VAL C 207 SHEET 1 AB2 4 VAL H 5 SER H 7 0 SHEET 2 AB2 4 SER H 21 ALA H 23 -1 O SER H 21 N SER H 7 SHEET 3 AB2 4 SER H 78 MET H 83 -1 O LEU H 79 N CYS H 22 SHEET 4 AB2 4 PHE H 68 SER H 71 -1 N THR H 69 O GLN H 82 SHEET 1 AB3 5 GLY H 59 TYR H 60 0 SHEET 2 AB3 5 LEU H 45 THR H 50 -1 N THR H 50 O GLY H 59 SHEET 3 AB3 5 MET H 34 GLN H 39 -1 N ARG H 38 O GLU H 46 SHEET 4 AB3 5 ALA H 97 ASP H 99 -1 O ALA H 97 N HIS H 35 SHEET 5 AB3 5 MET H 109 TRP H 112 -1 O VAL H 111 N LYS H 98 SHEET 1 AB4 2 LEU H 93 TYR H 94 0 SHEET 2 AB4 2 THR H 116 THR H 117 -1 O THR H 116 N TYR H 94 SHEET 1 AB5 3 SER H 129 LEU H 133 0 SHEET 2 AB5 3 THR H 144 LYS H 152 -1 O LYS H 152 N SER H 129 SHEET 3 AB5 3 SER H 186 PRO H 194 -1 O VAL H 191 N LEU H 147 SHEET 1 AB6 3 THR H 160 TRP H 163 0 SHEET 2 AB6 3 ILE H 204 ASN H 208 -1 O ASN H 206 N SER H 162 SHEET 3 AB6 3 VAL H 216 LYS H 219 -1 O VAL H 216 N VAL H 207 SHEET 1 AB7 2 LEU L 4 GLN L 6 0 SHEET 2 AB7 2 CYS L 23 ALA L 25 -1 O ARG L 24 N THR L 5 SHEET 1 AB8 3 THR L 20 LEU L 21 0 SHEET 2 AB8 3 ASP L 70 THR L 74 -1 O LEU L 73 N LEU L 21 SHEET 3 AB8 3 SER L 63 SER L 67 -1 N SER L 65 O THR L 72 SHEET 1 AB9 4 ARG L 45 TYR L 49 0 SHEET 2 AB9 4 ALA L 34 GLN L 38 -1 N GLN L 37 O ARG L 45 SHEET 3 AB9 4 VAL L 85 GLN L 89 -1 O TYR L 87 N TYR L 36 SHEET 4 AB9 4 THR L 102 ARG L 103 -1 O THR L 102 N TYR L 86 SHEET 1 AC1 2 ALA L 130 PHE L 139 0 SHEET 2 AC1 2 TYR L 173 LEU L 181 -1 O LEU L 175 N LEU L 136 SHEET 1 AC2 4 ALA L 153 LEU L 154 0 SHEET 2 AC2 4 LYS L 145 VAL L 150 -1 N VAL L 150 O ALA L 153 SHEET 3 AC2 4 TYR L 192 THR L 197 -1 O GLU L 195 N GLN L 147 SHEET 4 AC2 4 VAL L 205 SER L 208 -1 O VAL L 205 N VAL L 196 SSBOND 1 CYS A 167 CYS A 183 1555 1555 2.04 SSBOND 2 CYS D 23 CYS D 88 1555 1555 2.03 SSBOND 3 CYS D 134 CYS D 194 1555 1555 2.03 SSBOND 4 CYS C 22 CYS C 96 1555 1555 2.03 SSBOND 5 CYS C 149 CYS C 205 1555 1555 2.03 SSBOND 6 CYS H 22 CYS H 96 1555 1555 2.03 SSBOND 7 CYS H 149 CYS H 205 1555 1555 2.03 SSBOND 8 CYS L 23 CYS L 88 1555 1555 2.03 SSBOND 9 CYS L 134 CYS L 194 1555 1555 2.03 SSBOND 10 CYS B 167 CYS B 183 1555 1555 2.03 LINK CA GLY A 68 CAC Y01 A 302 1555 1555 1.49 LINK NZ LYS B 50 OAW Y01 B 301 1555 1555 1.30 LINK CZ PHE B 203 CAC Y01 B 303 1555 1555 1.49 CISPEP 1 TRP D 94 PRO D 95 0 -3.03 CISPEP 2 TYR D 140 PRO D 141 0 -0.63 CISPEP 3 PHE C 155 PRO C 156 0 -2.30 CISPEP 4 GLU C 157 PRO C 158 0 -3.75 CISPEP 5 PHE H 155 PRO H 156 0 -2.29 CISPEP 6 GLU H 157 PRO H 158 0 -3.80 CISPEP 7 TRP L 94 PRO L 95 0 -2.88 CISPEP 8 TYR L 140 PRO L 141 0 -0.72 SITE 1 AC1 3 SER A 188 GLY A 192 Y01 B 304 SITE 1 AC2 5 GLY A 67 GLY A 68 LEU A 69 MET A 71 SITE 2 AC2 5 Y01 B 302 SITE 1 AC3 5 Y01 A 302 TYR B 184 SER B 188 LEU B 191 SITE 2 AC3 5 GLY B 192 SITE 1 AC4 3 Y01 A 301 GLY B 68 MET B 71 SITE 1 AC5 5 GLU B 48 SER B 49 THR B 51 LEU B 52 SITE 2 AC5 5 ALA B 54 SITE 1 AC6 9 ALA A 54 ILE B 199 PHE B 200 ALA B 201 SITE 2 AC6 9 PHE B 202 GLN B 204 GLU B 205 LEU B 206 SITE 3 AC6 9 VAL B 207 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000